All episodes

Exercise is Medicine - Physical Activity and Insulin Action in Diabetes

Exercise is Medicine - Physical Activity and Insulin Action in Diabetes

10m 27s

In this episode, we sit down with Prof. Juleen Zierath, recipient of the 2024 EASD-Novo Nordisk Foundation Diabetes Prize for Excellence. A former EASD President, Prof. Zierath shares insights from her pioneering research on the role of exercise in diabetes management, exploring how physical activity can improve glucose metabolism, insulin sensitivity, and overall metabolic health. She also discusses the impact of circadian rhythms on metabolism, the mysteries of insulin action, and the future of precision medicine in diabetes care.

Islet Networks Regulating Insulin Secretion - A Debate

Islet Networks Regulating Insulin Secretion - A Debate

9m 57s

The role of beta cells in diabetes is well established, but how important are the other cells within the islet network?
In this episode of Diabetes Insights, Prof. Mark Huising (University of California) and Prof. Guy Rutter (Imperial College London) dive into the intricate crosstalk between islet cells and its impact on insulin secretion and glucose regulation. They debate the influence of alpha and delta cells on beta cell function and explore whether these interactions could hold the key to better diabetes treatments.

Diabetologia Journal in Review - Innovations, AI and the Future of Diabetes Research

Diabetologia Journal in Review - Innovations, AI and the Future of Diabetes Research

9m 45s

In this episode, Prof. Hindrik Mulder, Editor-in-Chief of Diabetologia, joins us to discuss the journals accomplishments over the past year and its vision for the future of diabetes research. From embracing AI in research processes to addressing global health disparities, Prof. Mulder highlights how Diabetologia remains at the forefront of the field.

He also shares his excitement about advancements in stem-cell and beta-cell research, the potential of precision medicine, and the role of incretin-based therapies, Prof. Mulder previews Diabetologia's special symposium on technology in diabetes care, co-created with patients, and explores how collaborative efforts are driving innovation in treatment and...

Talking Guidelines - New Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Diseases

Talking Guidelines - New Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Diseases

17m 21s

In this episode, Prof. Frank Tacke (Charité – Universitätsmedizin Berlin), Prof. Michael Roden (University of Düsseldorf), and Prof. Hannele Yki-Järvinen (University of Helsinki) discuss the groundbreaking new guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD).
The episode explores the shift from the term "NASH" to MASLD, addressing the rationale behind this change and its implications for reducing stigma and improving diagnosis. The experts delve into innovative diagnostic tools, such as FIB-4 and transient elastography, and the evolving role of GLP-1 receptor agonists and emerging liver-specific therapies.
Join us to learn how multidisciplinary collaboration between hepatologists, diabetologists, and obesity specialists is...

Putting Diabetes on the Agenda - How to Get Policymakers on Board

Putting Diabetes on the Agenda - How to Get Policymakers on Board

10m 1s

In this episode, we explore the vital role of National and European diabetes forums, respectively, in shaping policies and improving care for people living with diabetes. Featuring Bogdan Timor (Romanian Diabetes Forum) and Frank Nobels (Belgian Diabetes Forum), the discussion highlights how collaborative efforts, and shared strategies can drive early detection, prevention, and better management of diabetes across Europe. From Romania's groundbreaking diabetes prevention law to Belgium's integrated care and data projects, this episode showcases the power of collective advocacy in transforming diabetes care.

Help! I Need Somebody - Complex Diabetes Cases in the Emergency Room

Help! I Need Somebody - Complex Diabetes Cases in the Emergency Room

10m 11s

In this episode, Aoife Egan and Daniel Morganstein discuss the complexities of managing glycaemic emergencies in special patient populations. From diabetic ketoacidosis (DKA) during pregnancy to hypoglycaemic crises triggered by cancer treatments, they explore the importance of multidisciplinary collaboration, education, and awareness in delivering timely and effective care.

Once Weekly Insulins - A Paradigm Change for Basal Insulin Replacement

Once Weekly Insulins - A Paradigm Change for Basal Insulin Replacement

11m 57s

QWINT: A Paradigm Shift in Insulin Therapy

In this episode, Harpreet Bajaj, Carol Wysham, and Richard Bergenstal explore the revolutionary QWINT program, a once-weekly insulin therapy currently in development. With a unique mechanism of action resulting in a 17-day half-life, QWINT has the potential to transform diabetes care by reducing the treatment burden for patients and caregivers alike.

The discussion covers key findings from the program’s trials, including strong patient preference despite challenges in type 1 diabetes management, and highlights the benefits for older patients and those requiring assistance with daily activities. Join us to learn how QWINT is poised...

The Future of Type 1 Diabetes - Will We See Prevention or Cure?

The Future of Type 1 Diabetes - Will We See Prevention or Cure?

18m 20s

In this first episode of the year, our very own president Prof. Chantal Mathieu and other leading experts explore the future of type 1 diabetes. Join Vivienne Parry as she sits down with renowned experts - EASD President Prof. Chantal Mathieu, Dr. Peter Rossing, and Dr. Rory McCrimmon - to discuss the future of type 1 diabetes.
From global screening initiatives to cutting-edge research on islet transplantation and organ protection, this conversation highlights how far we've come - and the exciting journey ahead!
Tune in for insights from experts dedicated to improving lives through groundbreaking research and solutions.

Identifying the Genetic Causes of Neonatal Diabetes

Identifying the Genetic Causes of Neonatal Diabetes

9m 47s

In this episode, Dr Elisa De Franco, recipient of the 2024 EASD Minkowski Award, takes us on a journey through her groundbreaking research into neonatal diabetes. Dr De Franco’s work has revolutionised the understanding and treatment of this rare form of diabetes, diagnosed in babies under six months old. From identifying 10 - 15 genetic mutations linked to neonatal diabetes to shedding light on beta cell biology, Elisa’s discoveries are transforming lives and advancing diabetes research.

Join us to explore the global impact of Exeter's diagnostic service, the role of next-generation sequencing in genetic research, and how rare genetic mutations...

Metabolic Mastermind - Adipose Tissue's Role in Energy and Glucose Control

Metabolic Mastermind - Adipose Tissue's Role in Energy and Glucose Control

9m 9s

Adipose tissue isn't just "fat" - it's a remarkable endocrine organ with transformative impacts on health and diabetes. In this episode, discover groundbreaking insights from Dr Alice Williamson of Queen Mary University, London, and Dr Lori Goodyear of Harvard Medical School.
Learn about the genetic factors behind insulin resistance and the revolutionary role of exercise in remodelling adipose tissue. From genetic breakthroughs to potential therapies, this discussion unpacks the future of diabetes care. Find out why fat is more than just a roll around your middle - it’s a key player in metabolic health!